The report highlights Eurofarma's commitment to sustainability, including its commitment to neutralize 100% of its direct CO2 emissions, its agreement for self-production of wind energy, and its issuance of its first sustainable bond. The report also highlights Eurofarma's focus on innovation, including the inauguration of Eurolab in 2020, one of the largest and most modern pharmaceutical research centers in Latin America, and the development of a number of new products. Additionally, Eurofarma has been recognized for its commitment to its employees, including its ranking among the best companies to work for in Brazil and its inclusion of a diversity and inclusion program.
Issuing Company Eurofarma Laboratorios S.A.
Report Type Sustainability Report
Report Language EN
Report Filesize 39.55 MB
No. of Pages 68 pages
Reporting periodJanuary 1-December 31, 2022
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue